Professor of Psychiatry and Behavioral Sciences
Marjorie Bintliff Johnson and Raleigh White Johnson, Jr. Chair for Research in Psychiatry
Menninger Department of Psychiatry & Behavioral Sciences
Baylor College of Medicine
Houston, TX, US
Mood and Anxiety Disorders Program
Baylor College of Medicine
Houston, Texas, United States


Fellowship at Columbia University College Of Physicians And Surgeons
Residency at New York State Psychiatric Institute
MD from Baylor College Of Medicine
AB from Dartmouth College


Board Certified
American Board of Psychiatry and Neurology
State of Texas Medical License

Professional Interests

  • Psychopharmacology
  • Treatment-resistant depression and anxiety
  • Biomarker research

Professional Statement

My clinical expertise is in the psychopharmacological management of adult patients with difficult-to-treat depressive and anxiety disorders.

Selected Publications


Society of Biological Psychiatry
Anxiety and Depression Association of America
American College of Neuropsychopharmacology
American Psychiatric Association
American Medical Association


A Phase 2a study to evaluate the kappa opioid receptor as a target for the treatment of mood and anxiety spectrum disorders by evaluating whether LY2456302 engages key neural circuitry related to the hedonic response
Grant funding from National Institutes of Health
Double-blind, placebo-controlled, proof-of-concept trial of ketamine therapy in treatment-resistant depression
National Institutes of Health
Efficacy and Tolerability of Riluzole in Treatment-Resistant Depression
National Institutes of Health
A double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of intranasal esketamine
Janssen Research and Development